Hereditary angioedema: Implications of treating a rare disease

Annals of Allergy, Asthma and Immunology

Volumn 109, Issue 2, 2012, Pages 150-151

  Kalfus, Ira N ^a   Gower, Richard Glen ^b   Riedl, Marc ^c   Bernstein, Jonathan A ^d   Lumry, William R ^d,e   Frank, Michael M ^f  

^a M2G Consulting   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; ORPHAN DRUG;

ANGIONEUROTIC EDEMA; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG RESEARCH; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; INVESTMENT; LETTER; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT SAFETY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; RARE DISEASE; UNITED STATES;

ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84864407891     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.06.011     Document Type: Letter

References (8)

1. M. Riedl, R.G. Gower, C.A. Chrvala Current medical management of hereditary angioedema: results from a large survey of US physicians Ann Allergy Asthma Immunol 106 2011 316 322
2. J.A. Gelfand, R.J. Sherins, D.W. Alling, M.M. Frank Treatment of hereditary angioedema with danazol N Engl J Med 295 1976 1444 1448
3. J.A. Gader, S.W. Hosea, J.A. Gelfand Replacement therapy in hereditary angioedema N Engl J Med 302 1980 542 546
4. A.T. Waytes, F.S. Rosen, M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634 (Pubitemid 26192522)
5. S. Tilles, L. Borish A new generation of hereditary angioedema treatments: remarkable advances clash with disturbing economic reality Ann Allergy Asthma Immunol 106 2011 264 266
6. T. Craig, M. Riedl, M.S. Dykewics When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 102 2009 366 372
7. Herper M. The world's most expensive drugs. Forbes.com. 02:22:10.
8. D.A. Wilson, K. Bork, E.P. Shea Economic costs associated with acute attacks and long term management of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 314 320